A PDX/Organoid Biobank of Advanced Prostate Cancers Captures Genomic and Phenotypic Heterogeneity for Disease Modeling and Therapeutic ScreeningMichael L. Beshiri, Kathleen Kelly, Caitlin M. Tice et al.|Clinical Cancer Research|2018Cited by 236
EGR1 regulates angiogenic and osteoclastogenic factors in prostate cancer and promotes metastasisLechen Li, Kathleen Kelly, Lei Fang et al.|Oncogene|2019Cited by 172
Platelets Promote Metastasis via Binding Tumor CD97 Leading to Bidirectional Signaling that Coordinates Transendothelial MigrationYvona Ward, Kathleen Kelly, Ross Lake et al.|Cell Reports|2018Cited by 163
Gambogic acid inhibits thioredoxin activity and induces ROS-mediated cell death in castration-resistant prostate cancerHong Pan, Kathleen Kelly, Keith H. Jansson et al.|Oncotarget|2017Cited by 45
Tumor-derived biomarkers predict efficacy of B7H3 antibody-drug conjugate treatment in metastatic prostate cancer modelsSupreet Agarwal, Kathleen Kelly, Lei Fang et al.|Journal of Clinical Investigation|2023Cited by 33